Riverwater Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Riverwater Partners's VRTX Position: Q2 2026 in Review
Riverwater Partners increased its Vertex Pharmaceuticals (VRTX) stake by 7.2% in Q2 2026, buying an estimated $16.8K and bringing the position to 563 shares worth $280K. The position accounts for 0.08% of the portfolio, ranked #182.
Riverwater Partners first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Riverwater Partners held 563 shares of Vertex Pharmaceuticals worth $280K as of Q2 2026.
- Riverwater Partners bought 38 Vertex Pharmaceuticals shares in Q2 2026, an estimated $16.8K.
- Vertex Pharmaceuticals made up 0.08% of Riverwater Partners's portfolio in Q2 2026, its #182 holding.
- Riverwater Partners first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.